Lv1
10 积分 2021-10-16 加入
Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial
1个月前
已完结
Contemporary medical, device, and surgical therapies for obesity in adults
1个月前
已完结
Benefits of bariatric surgery prevail
1个月前
已关闭
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
1个月前
已完结
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
1个月前
已完结
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
1个月前
已完结
Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes
1个月前
已完结
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial
1个月前
已完结
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
1个月前
已完结
Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial
1个月前
已完结
皖公网安备34019202002308
